The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 50, Issue 2, Pages 233-244
Publisher
Informa UK Limited
Online
2014-12-17
DOI
10.3109/00365521.2014.990505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
- (2014) Jean–Michel Pawlotsky GASTROENTEROLOGY
- Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
- (2014) Xavier Forns et al. GASTROENTEROLOGY
- The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
- (2014) H. Razavi et al. JOURNAL OF VIRAL HEPATITIS
- Strategies to manage hepatitis C virus (HCV) disease burden
- (2014) H. Wedemeyer et al. JOURNAL OF VIRAL HEPATITIS
- Historical epidemiology of hepatitis C virus (HCV) in selected countries
- (2014) P. Bruggmann et al. JOURNAL OF VIRAL HEPATITIS
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort
- (2014) Jenny Stenkvist et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients
- (2013) A. H. Talal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis
- (2013) Soo Aleman et al. CLINICAL INFECTIOUS DISEASES
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study
- (2013) Michael W. Fried et al. HEPATOLOGY
- Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
- (2013) Natasha K. Martin et al. HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- HCV direct-acting antiviral agents: the best interferon-free combinations
- (2013) Raymond Schinazi et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations
- (2012) Martin Lagging et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden
- (2011) Magdalena Ydreborg et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- The burden of hepatitis C in Sweden: a national study of inpatient care
- (2010) A.-S. Duberg et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Treatment of hepatitis C virus infection: Updated Swedish Consensus recommendations
- (2009) Martin Lagging et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Hepatitis C infection among injection drug users in Stockholm Sweden: Prevalence and gender
- (2009) Christer Lidman et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
- (2008) Marina Berenguer JOURNAL OF HEPATOLOGY
- Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin
- (2008) O. Weiland et al. JOURNAL OF VIRAL HEPATITIS
- Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study
- (2008) Ann-Sofi Duberg et al. JOURNAL OF VIRAL HEPATITIS
- Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis
- (2008) Eliya Syed et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started